Anti-cancer peptide-based therapeutic strategies in solid tumors

Author:

Karami Fath Mohsen,Babakhaniyan Kimiya,Zokaei Maryam,Yaghoubian Azadeh,Akbari Sadaf,Khorsandi Mahdieh,Soofi Asma,Nabi-Afjadi Mohsen,Zalpoor Hamidreza,Jalalifar Fateme,Azargoonjahromi Ali,Payandeh ZahraORCID,Alagheband Bahrami Armina

Abstract

Abstract Background Nowadays, conventional medical treatments such as surgery, radiotherapy, and chemotherapy cannot cure all types of cancer. A promising approach to treat solid tumors is the use of tumor-targeting peptides to deliver drugs or active agents selectively. Result Introducing beneficial therapeutic approaches, such as therapeutic peptides and their varied methods of action against tumor cells, can aid researchers in the discovery of novel peptides for cancer treatment. The biomedical applications of therapeutic peptides are highly interesting. These peptides, owing to their high selectivity, specificity, small dimensions, high biocompatibility, and easy modification, provide good opportunities for targeted drug delivery. In recent years, peptides have shown considerable promise as therapeutics or targeting ligands in cancer research and nanotechnology. Conclusion  This study reviews a variety of therapeutic peptides and targeting ligands in cancer therapy. Initially, three types of tumor-homing and cell-penetrating peptides (CPPs) are described, and then their applications in breast, glioma, colorectal, and melanoma cancer research are discussed.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference205 articles.

1. Gerber DE. Targeted therapies: a new generation of cancer treatments. Am Fam Phys. 2008;77(3):311–9.

2. Nguyen KT. Targeted nanoparticles for cancer therapy: promises and challenge. 2011.

3. Payandeh Z, Tazehkand AP, Mansoori B, Khaze V, Asadi M, Baradaran B, et al. The Impact of Nrf2 Silencing on Nrf2-PD-L1 axis to overcome oxaliplatin resistance and migration in colon cancer cells. Avicenna J Med Biotechnol. 2021;13(3):116.

4. Alibolandi M, Ramezani M, Abnous K, Sadeghi F, Hadizadeh F. Comparative evaluation of polymersome versus micelle structures as vehicles for the controlled release of drugs. J Nanopart Res. 2015;17(2):1–16.

5. Mohammadi M, Ramezani M, Abnous K, Alibolandi M. Biocompatible polymersomes-based cancer theranostics: towards multifunctional nanomedicine. Int J Pharm. 2017;519(1–2):287–303.

Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3